197 related articles for article (PubMed ID: 22031819)
1. Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines.
Costa SM; Yorio AP; Gonçalves AJ; Vidale MM; Costa EC; Mohana-Borges R; Motta MA; Freire MS; Alves AM
PLoS One; 2011; 6(10):e25685. PubMed ID: 22031819
[TBL] [Abstract][Full Text] [Related]
2. Differential humoral and cellular immunity induced by vaccination using plasmid DNA and protein recombinant expressing the NS3 protein of dengue virus type 3.
Hurtado-Melgoza ML; Ramos-Ligonio A; Álvarez-Rodríguez LM; Meza-Menchaca T; López-Monteon A
J Biomed Sci; 2016 Dec; 23(1):85. PubMed ID: 27903271
[TBL] [Abstract][Full Text] [Related]
3. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
Front Immunol; 2019; 10():1522. PubMed ID: 31333657
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III.
Azevedo AS; Yamamura AM; Freire MS; Trindade GF; Bonaldo M; Galler R; Alves AM
PLoS One; 2011; 6(7):e20528. PubMed ID: 21779317
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell-mediated immune responses in mice by DNA vaccines that express hepatitis C virus NS3 mutants lacking serine protease and NTPase/RNA helicase activities.
Ratnoglik SL; Jiang DP; Aoki C; Sudarmono P; Shoji I; Deng L; Hotta H
PLoS One; 2014; 9(6):e98877. PubMed ID: 24901478
[TBL] [Abstract][Full Text] [Related]
6. Recombinant dengue 2 virus NS3 protein conserves structural antigenic and immunological properties relevant for dengue vaccine design.
Ramírez R; Falcón R; Izquierdo A; García A; Alvarez M; Pérez AB; Soto Y; Muné M; da Silva EM; Ortega O; Mohana-Borges R; Guzmán MG
Virus Genes; 2014 Oct; 49(2):185-95. PubMed ID: 24854144
[TBL] [Abstract][Full Text] [Related]
7. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Dengue 2 Virus NS3 Helicase Protein Enhances Antibody and T-Cell Response of Purified Inactivated Vaccine.
Simmons M; Sun P; Putnak R
PLoS One; 2016; 11(4):e0152811. PubMed ID: 27035715
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.
Costa SM; Azevedo AS; Paes MV; Sarges FS; Freire MS; Alves AM
Virology; 2007 Feb; 358(2):413-23. PubMed ID: 17020777
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice.
Wu SF; Liao CL; Lin YL; Yeh CT; Chen LK; Huang YF; Chou HY; Huang JL; Shaio MF; Sytwu HK
Vaccine; 2003 Sep; 21(25-26):3919-29. PubMed ID: 12922127
[TBL] [Abstract][Full Text] [Related]
11. Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge.
Henriques HR; Rampazo EV; Gonçalves AJ; Vicentin EC; Amorim JH; Panatieri RH; Amorim KN; Yamamoto MM; Ferreira LC; Alves AM; Boscardin SB
PLoS Negl Trop Dis; 2013; 7(7):e2330. PubMed ID: 23875054
[TBL] [Abstract][Full Text] [Related]
12. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
[TBL] [Abstract][Full Text] [Related]
13. Dendritic Cell Targeting Using a DNA Vaccine Induces Specific Antibodies and CD4
Zaneti AB; Yamamoto MM; Sulczewski FB; Almeida BDS; Souza HFS; Ferreira NS; Maeda DLNF; Sales NS; Rosa DS; Ferreira LCS; Boscardin SB
Front Immunol; 2019; 10():59. PubMed ID: 30761131
[TBL] [Abstract][Full Text] [Related]
14. Combination of E- and NS1-Derived DNA Vaccines: The Immune Response and Protection Elicited in Mice against DENV2.
Pinto PBA; Barros TAC; Lima LM; Pacheco AR; Assis ML; Pereira BAS; Gonçalves AJS; Azevedo AS; Neves-Ferreira AGC; Costa SM; Alves AMB
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891431
[TBL] [Abstract][Full Text] [Related]
15. DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.
Mellado-Sánchez G; García-Cordero J; Luria-Pérez R; Lázaro-Olan L; Santos-Argumedo L; Gutiérrez-Castañeda B; Estrada-García I; Cedillo-Barrón L
Viral Immunol; 2005; 18(4):709-21. PubMed ID: 16359237
[TBL] [Abstract][Full Text] [Related]
16. The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids.
Li H; Clum S; You S; Ebner KE; Padmanabhan R
J Virol; 1999 Apr; 73(4):3108-16. PubMed ID: 10074162
[TBL] [Abstract][Full Text] [Related]
17. Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.
Costa SM; Paes MV; Barreto DF; Pinhão AT; Barth OM; Queiroz JL; Armôa GR; Freire MS; Alves AM
Vaccine; 2006 Jan; 24(2):195-205. PubMed ID: 16122850
[TBL] [Abstract][Full Text] [Related]
18. The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue.
Azevedo AS; Gonçalves AJ; Archer M; Freire MS; Galler R; Alves AM
PLoS One; 2013; 8(3):e58357. PubMed ID: 23472186
[TBL] [Abstract][Full Text] [Related]
19. Production of a Recombinant Dengue Virus 2 NS5 Protein and Potential Use as a Vaccine Antigen.
Alves RPDS; Pereira LR; Fabris DLN; Salvador FS; Santos RA; Zanotto PMA; Romano CM; Amorim JH; Ferreira LCS
Clin Vaccine Immunol; 2016 Jun; 23(6):460-469. PubMed ID: 27030586
[TBL] [Abstract][Full Text] [Related]
20. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
